X-86695102-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_053281.3(DACH2):c.854C>A(p.Ala285Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000243 in 1,151,793 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_053281.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DACH2 | NM_053281.3 | c.854C>A | p.Ala285Glu | missense_variant | 5/12 | ENST00000373125.9 | NP_444511.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DACH2 | ENST00000373125.9 | c.854C>A | p.Ala285Glu | missense_variant | 5/12 | 1 | NM_053281.3 | ENSP00000362217.4 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111571Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33739
GnomAD3 exomes AF: 0.0000560 AC: 8AN: 142731Hom.: 0 AF XY: 0.0000475 AC XY: 2AN XY: 42145
GnomAD4 exome AF: 0.0000240 AC: 25AN: 1040222Hom.: 0 Cov.: 29 AF XY: 0.0000304 AC XY: 10AN XY: 329024
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111571Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33739
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2022 | The c.854C>A (p.A285E) alteration is located in exon 5 (coding exon 5) of the DACH2 gene. This alteration results from a C to A substitution at nucleotide position 854, causing the alanine (A) at amino acid position 285 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at